Educational article
VRE and vancomycin resistance
VRE are vancomycin-resistant enterococci. Some van systems alter the peptidoglycan precursor terminus and reduce drug binding. VanA and VanB differ in phenotype and regulation; intrinsic VanC-associated resistance…
Overview
VRE are vancomycin-resistant enterococci. Some van systems alter the peptidoglycan precursor terminus and reduce drug binding. VanA and VanB differ in phenotype and regulation; intrinsic VanC-associated resistance occurs in particular species.
Biology and practical meaning
VRE colonisation is not infection but can matter for infection prevention. Gene screening, culture identification and AST provide different evidence. Transferable determinants matter for surveillance; similar antibiograms across isolates do not prove a single clone.
Connecting gene, mechanism and phenotype
A genetic determinant, activity of its product and the measured phenotype are connected levels, not a single result. Permeability, efflux, enzymes and target changes can contribute simultaneously. Their effects depend on species, genetic background and expression.
A positive gene assay confirms its specified target in the tested material. In a mixed specimen, the gene’s connection to a particular organism may remain uncertain. A negative result is limited by the panel and assay characteristics; it cannot exclude unknown mechanisms or targets outside the panel.
Reports should retain the method, gene or family, AST findings and interpretive standard. Discordance calls for assessment of quality and context rather than selecting the convenient answer. The same gene in two patients does not prove direct transmission: genetic surroundings and epidemiological evidence matter. A mechanism helps explain biology and guide confirmation, but does not provide the entire susceptibility profile or independently determine treatment.
Sources
Read next
Educational material from AMR Atlas. Does not replace clinical guidance or laboratory procedures.